foxo4-dri peptide mechanism of action Development a novel senolytic by precise disruption of FOXO4-p53 complex BPC-157 + TB-500 Peptides Category_Cognitive Support Size:10mg/10mg
BPC-157 + TB-500 Peptides | Intra|V
FOXO4-DRI effectively improves vascular function in prematurely aging mice To further explore the role of FOXO4-DRI in aged mice, we constructed prematurely aging mouse model by administering D-galactose (200 mg/kg) intraperitoneally for 8 weeks
Category_Cognitive Support
Size:10mg/10mg
- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)